Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0000876661-22-000365
Filing Date
2022-04-13
Accepted
2022-04-13 09:15:46
Documents
1
Effectiveness Date
2022-04-13

Document Format Files

Seq Description Document Type Size
1 NYSE AMERICAN CERTIFICATION NAVB041322.pdf CERT 466992
  Complete submission text file 0000876661-22-000365.txt   644484
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-35076 | Film No.: 22823813
SIC: 2835 In Vitro & In Vivo Diagnostic Substances